Life WhispererLife WhispererLife WhispererLife Whisperer
  • How it works
  • Team
  • Patients
  • Clinics
  • Global
  • News
  • IVF-X
  • FAQs
  • Contact
  • Home
  • How it works
  • Team
  • Patients
  • Clinics
  • Global
  • News
  • IVF-X
  • FAQs
  • Contact

Life Whisperer secures TechInSA funding to accelerate commercial growth of its embryo selection technology for IVF

IVF Embryo Selection

Life Whisperer, an AI startup in the fertility sector, has secured its first round of funding through the SA Early Commercialization Fund initiative administered by TechInSA. The fund is designed to support the commercialization of innovative technologies that have global market potential. 

The funding will support secondary validation of Life Whisperer’s approach, which applies AI-driven image analysis such as machine learning, as well as morphological assessment of embryos to assist in the selection of healthy embryos for IVF implantation.

Dr Michelle Perugini says “the South Australian government recognizes the value of providing support to companies with innovative ideas, and we hope to give back by building a world-leading capability for clinical decision support”.

Life Whisperer will use the funding to assist in the development of a scalable cloud-based software product that provides image analysis for embryo selection to clinics who perform IVF globally.

The value of Life Whisperer is that it is a completely non-invasive approach to analyzing embryos. Dr Jonathan Hall says “our approach does not require significant process change, does not tamper with the embryos, and does not require specialized hardware. This will hopefully reduce the barriers to use by clinics for this type of approach, and will see patients benefiting from the technology sooner.”

Life Whisperer plans to work with commercial partners to complete the next phase of validation.

For more information email Info@LifeWhisperer.co or Dr Michelle Perugini on +61 412 396 960.

Connect with us
Share
68

Related posts

November 20, 2022

New study shows that Artificial Intelligence can help women find good quality eggs to support IVF and egg freezing


Read more
November 7, 2022

Life Whisperer Genetics AI is predictive of live birth outcomes


Read more
November 1, 2022

Combined use of two AI algorithms for evaluating embryo quality improves selection of embryos leading to clinical pregnancy


Read more
October 23, 2022

India’s most advanced and largest IVF clinic group, Indira IVF, will offer all patients Artificial Intelligence technology to improve pregnancy outcomes


Read more

Comments are closed.

Life Whisperer
A product by
Presagen parent company to Life Whisperer

Published in Human Reproduction by Oxford University Press.

Oxford University Logo

HIPAA and GDPR compliant and ISO 13485 certified

CE Logo

Authorized for sale in Australia, Canada, Europe (EEA), UK, Japan, India, UAE, Hong Kong, Israel, Malaysia, Thailand, Vietnam, Singapore, New Zealand, Turkey, Trinidad & Tobago, and Guyana.

Life Whisperer is not commercially available in the USA

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy